To facilitate survival under drug stresses, a small population of Mycobacterium tuberculosis can tolerate bactericidal concentrations of drugs without genetic mutations. These drug-tolerant mycobacteria can be induced by environmental stresses and contribute to recalcitrant infections. However, mechanisms underlying the development of drug-tolerant mycobacteria remain obscure. Herein, we characterized a regulatory pathway which is important for the tolerance to isoniazid (INH) in Mycobacterium smegmatis. We found that the RNA polymerase binding protein RbpA associates with the stress response sigma factor r B , to activate the transcription of ppk1, the gene encoding polyphosphate kinase. Subsequently, intracellular levels of inorganic polyphosphate increase to promote INH-tolerant mycobacteria. Interestingly, r B and ppk1 expression varied proportionately in mycobacterial populations and positively correlated with tolerance to INH in individual mycobacteria. Moreover, sigB and ppk1 transcription are both induced upon nutrient depletion, a condition that stimulates the formation of INHtolerant mycobacteria. Over-expression of ppk1 in rbpA knockdown or sigB deleted strains successfully restored the number of INH-tolerant mycobacteria under both normal growth and nutrient starved conditions. These data suggest that RbpA and r B regulate ppk1 expression to control drug tolerance both during the logarithmic growth phase and under the nutrition starved conditions.
Introduction
As one of the most successful pathogens, Mycobacterium tuberculosis (Mtb) employs distinct mechanisms to survive under drug exposure. One example of such a mechanism is by generating persisters that can survive at high concentrations of drugs without genetic modification (Zhang et al., 2012; Cohen et al., 2013; Jain et al., 2016) . Persisters of Escherichia coli are a marginal subpopulation of bacteria that evolve into a non-growing state (Balaban et al., 2004) . However, recent findings in Salmonella (Claudi et al., 2014) as well as in mycobacteria (Wakamoto et al., 2013) have demonstrated that persisters can arise from both non-growing and growing subpopulations (Balaban et al., 2013) . It was suggested that the metabolically active population of persisters should be renamed as drug-tolerant cells (Kim and Wood, 2017) .
During infection, drug-tolerant Mtb cells are enriched in the granulomas, where a series of stresses, for example, nutrient starvation, low pH and hypoxia are present (Ehrt and Schnappinger, 2009; Dutta and Karakousis, 2014) , suggesting that environmental stresses such as hypoxia may induce the generation of drug-tolerant Mtb cells. Consistently, several studies have established in vitro models to induce the formation of drug-tolerant Mtb cells using these stressors (Betts et al., 2002; Voskuil et al., 2004; Deb et al., 2009) . Drug-tolerant cells contribute to recalcitrant infections, relapse after drug therapy, and development of genetic resistance (Cohen et al., 2013; Fisher et al., 2017; Levin-Reisman et al., 2017) . However, the mechanisms underlying the formation of drug-tolerant bacilli remain obscure.
Several factors are important for generating drugtolerant cells. Intracellular inorganic polyphosphate (polyP), which regulates the protein degradosome (Kuroda et al., 2001; Germain et al., 2015) or RNA polymerase (RNAP) (Yang et al., 2010) , has been reported to be associated with the mycobacterial stress response as well as the formation of cells tolerant to the first-line anti-TB drug isoniazid (INH) (Thayil et al., 2011; Chuang et al., 2013; Singh et al., 2013; Chuang et al., 2015) . Deletion of ppk1, which encodes polyphosphate kinase (PPK1), reduced the number of INH-tolerant Mtb cells (Singh et al., 2013) . Deficiency of enzymes involved in polyP utilization increases intracellular polyP levels and decreases the susceptibility to INH (Thayil et al., 2011; Chuang et al., 2013 Chuang et al., , 2015 .
Transcriptional profiles of drug-tolerant cells are distinct from normal growing cells (Karakousis et al., 2008; Keren et al., 2011) , pointing to substantial rewiring of the transcriptome. Sigma factors in RNAP control the specificity of transcription in bacteria. The stress response r factor, r S , in Escherichia coli has been shown to be important for persistence (Radzikowski et al., 2016) . Mtb encodes a homologue of r S named
Previous studies have shown that deletion of Mtb sigB dramatically decreased bacterial survival under hypoxic conditions (Fontan et al., 2009) as well as in the presence of anti-tuberculosis drugs (Pisu et al., 2017) , suggesting that genes controlled by r B may play roles in generating drug-tolerant Mtb.
RbpA is an RNAP binding protein that regulates the activities of the principal sigma factor r A and the stress response r B in mycobacteria (Hu et al., 2012 (Hu et al., , 2014 .
Previous studies have shown that M. smegmatis (Msm) (Dey et al., 2010) and Streptomyces coelicolor (Newell et al., 2006) RbpA participate in rifampicin tolerance. Recently, we have shown that RbpA is also involved in tolerance to oxidative stress probably by its association with r A in mycobacteria (Hu et al., 2016) . Nevertheless, the consequences of the association between RbpA and r B in mycobacteria remain unknown.
In this study, the role of association between RbpA and r B in controlling drug-tolerance in mycobacteria was investigated. We compared the formation of INHtolerant cells in the logarithmic growth phase and under nutrient starved conditions between wild-type and rbpA knockdown, or sigB deleted strains. We demonstrated that RbpA and r B regulate ppk1 by monitoring the intracellular levels of polyP and the transcriptional levels of ppk1. Using fluorescence imaging, we found that expression levels of sigB and ppk1 vary proportionately in mycobacterial populations and positively correlate with tolerance to INH. Therefore, our study reports a regulatory pathway of RbpA-r B -PPK1 for controlling the development of both stochastically generated and nutritionally starved drug-tolerant mycobacterial cells.
Results

RbpA is required for INH-tolerance in Msm
To examine drug tolerance in mycobacteria, we examined Msm survival in the presence of different concentrations of INH at different time points. As shown in Fig. 1A , only a small percentage of INH-tolerant cells survived after 72 h of INH exposure (4.5%, 0.6% and 0.03% survived exposure to 30, 60 or 120 mg ml 21 INH, respectively, Fig. 1A) . However, the number of living cells began to increase after 72 h probably due to the generation of INH-resistant mutants (Fig. 1A) , which is consistent with previous results (Jain et al., 2016 et al., 1996) ] for 72 h was used in further experimentation, unless otherwise indicated. To investigate if RbpA was involved in susceptibility, we compared the survival of Msm strains with normal or repressed levels of RbpA in the presence of INH. Since rbpA was essential for mycobacterial growth (Bortoluzzi et al., 2013) , we constructed a rbpA knockdown strain named RbpAm-p (Hu et al., 2016) , in which the rbpA native promoter was replaced by an anhydrotetracycline (ATc) depressed ptr promoter (Supporting Information  Fig. S1A ). Addition of ATc to RbpAm-p repressed the mRNA levels of RbpA and bacterial growth (Hu et al., 2016) , but did not prevent bacterial survival (Supporting Information Fig. S1B) . Notably, the percentage survival of the rbpA knockdown strain (RbpAm-p) was significantly decreased when compared with the control strain (WT-p, wild-type strain carrying the pFRA42B plasmid) in the presence of ATc and 60 lg ml 21 of INH ( Fig. 1C and D); and the survival frequency was restored in the RbpA complemented strain (RbpAm-p-C) (Fig. 1E) . Furthermore, the majority of survivors of WT-p and RbpAm-p were confirmed to be INH-tolerant cells (Supporting Information Fig. S2A and B). These data suggest that RbpA may play a role in INH-tolerance during the Msm logarithmic growth phase.
RbpA participates in INH tolerance in the nutrient starvation model
We next used a nutrient starvation model (Betts et al., 2002) to test if RbpA is involved in the establishment of nutritionally induced drug-tolerant cells. To avoid bacterial clumping during starvation, we used PBST (phosphate buffered solution supplemented with 0.05% Tween 80) instead of PBS and used continuous shaking during the treatment. After being treated with PBST, bacteria entered a slow-growing state that was tolerant to INH ( Fig. 2A and B) . The PBST-treated bacteria demonstrated normal growth patterns after being resuspended in 7H9 medium and were once again susceptible to INH ( Fig. 2A and B) . These features indicate that PBST treated mycobacterial cells entered a drug-tolerant state as reported previously (Betts et al., 2002) . To characterize the role of RbpA in this process, RbpAm-p was cultured in the presence of INH after PBST treatment for 72 h. Knockdown expression of rbpA reduced survival of the cells compared with WT-p ( Fig. 2C ) and the percentage survival was restored in the RbpA complemented strain (Fig. 2D) . Survival of RbpAm-p in PBST in the absence of INH was comparable with WT-p strain (Supporting Information Fig. S3A ). Together, these data suggest that RbpA also plays a role in INH-tolerance in the nutrient starvation model.
RbpA controls the transcription of ppk1 and accumulation of polyP
The expression of peroxidase catalase (KatG) has been shown to be important for tolerance to INH in mycobacterial cells (Wakamoto et al., 2013) . In our previous study, we showed that RbpA activates the expression of KatG under oxidative stress conditions (Hu et al., 2016) . Therefore, we examined if RbpA regulates the participation of KatG in INH-tolerance by measuring the mRNA levels of katG in Msm WT-p and RbpAm-p under normal growth and PBST treated conditions. No obvious differences were observed between these two strains (Supporting Information Fig. S4A ), suggesting that RbpA regulates other targets to control INH susceptibility. Since increased intracellular polyP is known to be associated with increasing tolerance against INH (Thayil et al., 2011) , the ppk1 gene in Msm (Msmeg_2391, Dppk1; Supporting Information Fig. S1E ), which encodes polyP synthetase, was deleted and reduced intracellular polyP levels in Dppk1 were observed after PBST treatment for 2 and 4 h (Fig. 3A) . Percentages of INHtolerant cells in Dppk1 were decreased compared with Percentage survival of RbpAm-p strain carrying the pMV261 plasmid (RbpAm-p-V) and the complemented strain carrying the pMV261-RbpA (RbpAm-p-C) after treatment with 60 lg ml 21 INH for 72 h. The Msm WT-p strain transformed with the pMV261 plasmid (WT-p-V) was used as a control. All data are shown as mean 6 SEM (standard error of the mean) from both two biological replicates and at three technical replicates per sample. *p < 0.05; **p < 0.01. those in the WT strain both in the logarithmic growth phase ( Fig. 3B and Supporting Information Fig. S2C ) and under the nutrition starved conditions ( Fig. 3B and Supporting Information Fig. S3B) . Since the intracellular level of polyP in Msm was reduced to normal levels after PBST treatment for 8 h (Fig. 3A) (Thayil et al., 2011) , and we used PBST treatment for 72 h for INH susceptibility test in our studies, we determined the survival of Msm in the presence of INH after PBST treatment for different lengths of time. We consistently observed that after 2 h of PBST treatment 50% of Msm wild-type strain survived, and after 4 h of PBST treatment, survival was increased to 90% (Supporting Information Fig. S4B ). These data indicate that the transient accumulation of polyP in the early phase of starvation may facilitate the formation of INH-tolerant mycobacteria. 5-Aminosalicylic acid (5-ASA, also known as mesalamine) is an inhibitor of PPK1 (Dahl et al., 2017) and had no effect on the growth of Msm (Supporting Information Fig. S4C ). However, the accumulation of polyP was reduced (Supporting Information Fig. S4D ) (Dahl et al., 2017) , and the percentage of INH-tolerant cells in the logarithmic growth phase and under nutritionally starved conditions was reduced (Fig. 3B ). These data suggest that the PPK1-dependent polyP biosynthesis may play a role in INH-tolerance.
Therefore, we compared the concentrations of polyP in Msm WT-p and RbpAm-p strains after different lengths of time of PBST treatment. After PBST treatment for 2 and 4 h, the polyP levels were increased in WT-p, but they remained fairly constant in the RbpAm-p strain (Fig. 3C ). The RbpAm-C complemented strain behaved similarly to the WT-p (Fig. 3C ). These data suggest that RbpA controls polyP levels under nutrient starvation conditions.
To determine if ppk1 transcription is regulated by RbpA in mycobacteria, mRNA levels of ppk1 in RbpAmp were compared with that of the wild-type strain (WT-p). As shown in Fig. 3D , expression of ppk1 was induced in WT-p when treated with PBST, whereas this induction was not detected in RbpA-p. Importantly, overexpression of ppk1 in RbpAm-p restored the intracellular polyP level (Supporting Information Fig. S4E ) and the percentage of INH-tolerant cells both in the logarithmic growth phase and nutrient starvation models (Fig. 3E ). Taken together, these data suggest that RbpA plays a role in generating INH-tolerant cells through the regulation of ppk1 expression.
RbpA associates with r B to regulate ppk1 expression RbpA has been reported to activate transcription initiated via r A and r B (Hu et al., 2014) . To identify which r factor is involved in regulating ppk1 transcription, we tested expression levels of sigA and sigB after PBST treatment. After starvation treatment, mRNA levels of sigB were increased more than fivefold. In contrast, transcription of sigA was reduced by 40% ( Fig. 4A ).
Since sigA is essential for Msm (Gomez et al., 1998) , we constructed a sigA knockdown strain (SigAm-p, Supporting Information Fig. S1C and D) in a similar manner to RbpAm-p. The sigB gene is non-essential and was deleted in Msm to generate strain DsigB (Supporting Information Fig. S1F ). We next compared the expression of ppk1 in wild-type Msm, SigAm-p and the DsigB strains. Transcription of ppk1 was increased in the SigAm-p strain similar to that observed in the WT-p after PBST treatment (Fig. 4B ), whereas ppk1 transcription was not increased in DsigB (Fig. 4C ). Therefore, we propose that r B may play a role in the development of INH-tolerant cells. To support this hypothesis, the DsigB A. The CFU numbers of Msm wild-type strain before, during and regrowth after PBST treatment. Overnight culture of Msm was transferred into fresh 7H9 medium (1%) and was indicated as time 0 h. After incubation at 378C for 10 h (shown as Log phase), bacterial cells were transferred into PBST buffer and with incubation for another 120 h (shown as Starvation); after that, Msm cells were re-transferred into fresh 7H9 medium and incubated for another 28 h (shown as Regrowth). B. Tolerance of Msm to 60 lg ml 21 INH before (Log phase, incubated in 7H9 for 10 h), during (Starvation, PBST treated for 72 h), and regrowth (Regrowth, re-incubation in 7H9 for 10 h) after PBST treatment. Circle: starvation; rhombus: log phase; triangle: regrowth. C. Percentage survival of PBST-treated Msm WT-p, RbpAm-p and RbpAm-p complemented strains in the presence of INH at 60 lg ml 21 . All data are shown as mean 6 SEM from two biological replicates and at three technical replicates per sample. *p < 0.05; **p < 0.01. strain was treated with INH. Survival of the DsigB strain was markedly reduced when compared with that of WT strain both in the logarithmic growth phase and after PBST treatment ( Fig. 4D and Supporting Information Fig. S3B ). In addition, survivors of DsigB in the logarithmic growth phase contain approximately 40% of INHresistant mutants (Supporting Information Fig. S2D ). Together, these data suggest that the percentage of INH-tolerant cells in DsigB was much lower than that of the WT strain. Interestingly, over-expression of ppk1 in the DsigB strain restored the intracellular polyP level (Supporting Information Fig. S4F ) and the percentage survival in the presence of INH in both models (Fig. 4E) . These data indicate that activation of ppk1 transcription by RbpA may be mediated by r B in INH-tolerant cell formation.
Interaction between RbpA and r B regulates ppk1 transcription To test if protein-protein association between RbpA and r B is required for regulation of ppk1 expression, we constructed a mutated RbpA (RbpA-AA, Fig. 5A ), which is expected to be deficient in interacting with r factor, and a mutated r B (r B -VR, Fig. 5A ), which is expected to be deficient in interaction with RbpA (sequence alignments of RbpA and r B proteins are shown in Supporting
Information Fig. S5A and B) (Hubin et al., 2015 (Hubin et al., , 2017 . Protein-protein communications between these two mutated proteins were examined using the bacterial adenylate cyclase-based two-hybrid system (Karimova et al., 1998) . In contrast to interaction between the two wild-type alleles (Bortoluzzi et al., 2013; Tabib-Salazar et al., 2013) , the mutated alleles showed no proteinprotein association (Fig. 5B) . Next, expression of ppk1 in the RbpAm-p strain complemented with wild-type or mutated RbpA protein were measured. As shown in Fig.  5C , expression of wild-type RbpA protein in RbpAm-p restored ppk1 transcription after PBST treatment but not in mutated RbpA-AA, even though the relative transcription expression levels of wild-type and mutated rbpA were comparable (Supporting Information Fig. S5C ).
The percentage of INH-tolerant cells in both logarithmic growth cells and PBST-treated cells were restored by A. Intracellular polyP levels in Msm wild-type (WT) and ppk1 deleted (Dppk1) strains after PBST treatment. Time 0 h refers to the strains under normal growth conditions prior to PBST treatment. Data are the mean 6 SEM from three biological experiments that were performed in duplicate. B. Tolerance of Msm WT and Dppk1 strains to 60 mg ml 21 INH for 72 h in both the logarithmic growth phase and PBST treated conditions. The PPK1 inhibitor 5-ASA was added at 50 lg ml 21 where indicated; and DMSO was added as a control. C. Intracellular polyP levels in Msm rbpA knockdown and complementary strains after PBST treatment. D. Transcription levels of ppk1 gene in WT-p and RbpAm-p before and after PBST treatment. The transcription levels of ppk1 in WT-p strain before PBST treatment were normalized to 1. Mean 6 SEM values from two technical replicates and two biological replicates are shown. E. Effects of over-expressing PPK1 in the RbpAm-p strains on the formation of INH-tolerant cells. PPK1 was expressed by ATc inducible plasmid pUV15tetORm (Ehrt et al., 2005) . Survival of strains treated with 60 mg ml 21 INH for 72 h were examined. pUV represents strains carrying the control plasmid pUV15TetORm. ATc was added during the initial bacterial culturing and INH treatment of all strains. Surviving data are shown as mean 6 SEM from two biological experiments performed in triplicate. *p < 0.05; **p < 0.01. the expression of wild-type RbpA but not by the expression of RbpA-AA in the RbpAm-p strain (Fig. 5D) . Similarly, mutated r B -VR showed similar expression levels to wild-type r B in the DsigB strain (Supporting Information Fig. S5D ), but did not restore ppk1 transcription and the percentage of INH-tolerant cells during logarithmic phase growth or after PBST treatment ( Fig. 5E and F) . These data indicate that the interaction between RbpA and r B is essential for regulating ppk1 transcription during INH-tolerant cell formation.
RbpA and r B directly activate ppk1 transcription
The ppk1 gene is located in the middle of a conserved cluster consisting of three genes in both Mtb and Msm (Fig. 6A) . Similar to the ppk1 gene, transcriptional activation of the Msmeg_2392 gene, which is located upstream of ppk1 in Msm, requires RbpA and r B after
PBST treatment (Supporting Information Fig. S6 ). To test if ppk1 is transcribed together with Msmeg_2392, we used the transcription unit PCR assay (Hu et al., 2009) . As shown in Fig. 6A , three fragments covering the coding regions of Msmeg_2392 and ppk1 and the non-coding region between these two genes were obtained when using cDNA or genomic DNA as templates, while none of these fragments were amplified when RNA was used as a template. These data indicate that Msmeg_2392 and ppk1 are in the same transcriptional unit. A previous study has systematically identified the transcriptional start sites (TSS) in Mtb and has identified a TSS located at the first nucleotide of the Rv2983 gene (homologue of Msmeg_2392) (Shell et al., 2015) . We therefore analyzed the DNA sequences upstream of this TSS location in Mtb and Msm. A conserved 'TGn/-10' type of promoter (Agarwal and Tyagi, 2003) was identified 6 bp upstream of TSS in both species (Mtb_ppk1p and Msm_ppk1p, Fig. 6B ). As tested by fusing these promoters with the egfp gene, we found that both promoters were active, and their activities were both strictly dependent on the 'TGn/-10' sequences (Fig. 6B) , implying that the operon has a conserved promoter in mycobacteria. Importantly, complementation of Dppk1 using a plasmid carrying the Msm_ppk1p in fusion with A. Transcriptional levels of sigA and sigB in Msm after PBST treatment. RNA levels of these two genes before PBST treatment were normalized to 1 respectively. B,C. Relative transcriptional levels of ppk1 in sigA knockdown strain (SigAm-p) (B) and sigB deleted strain (DsigB) (C) before and after PBST treatment. ppk1 mRNA levels in WT-p or WT before PBST treatment was normalized to 1 respectively. Mean 6 SEM values from two biological replicates performed in duplicate in qRT-PCR assays are shown. D. Percentage survival of the sigB deleted strain in the presence of INH in the logarithmic growth phase or after treatment with PBST. E. Effect of over-expressing ppk1 in the DsigB strain on the formation of INH-tolerant cells. The Msm WT carrying the control plasmid pUV15tetORm (pUV) was used as a control. Survival data are shown as mean 6 SEM from two biological replicates performed in triplicate. *p < 0.05; **p < 0.01. the ppk1 gene successfully restored the formation of INH-tolerant cells (Fig. 6C ), but mutation of Msm_ppk1p (Msm_ppk1p-m) in this plasmid caused a deficiency in complementation (Fig. 6C) . These results indicate that the identified ppk1 promoter is essential for ppk1 transcription.
In vitro transcription was performed to determine if r B -RbpA directly activates this TGn/-10 promoter. As shown in Fig. 6D , wild-type r B and RbpA successfully activated transcription from both Mtb_ppk1p and Msm_ppk1p; and mutation in either r B or RbpA, which disrupts in interaction between these two proteins, prevented transcription from either of these two promoters (Fig. 6D) . Taken together, these data suggest that RbpA and r B associate to directly activate the ppk1 promoter in mycobacteria.
Variation in expression of PPK1 is coordinated with r
B levels in individual cells
After confirming that RbpA-r B regulation of ppk1 transcription is important for the formation of INH-tolerant cells, we next investigated if expression levels of ppk1 and sigB would be proportionate in individual cells. (Karimova et al., 1998) . C. Transcriptional levels of the ppk1 in the RbpAm-p strain complemented with wild-type or mutated RbpA. The ppk1 transcriptional levels in the strain complemented with the wild-type RbpA before PBST treatment was normalized to 1. D. Percentage survival of the RbpAm-p strain complemented with the wild-type or mutated RbpA in the presence of INH. E. Transcriptional levels of ppk1 gene in DsigB strain complemented with the wild-type or mutated r B . The ppk1 levels in the DsigB strain complemented with the wild-type r B before PBST treatment was normalized to 1. F. Percentage survival of DsigB strain complemented with the wild-type or mutated r B in the presence of INH. All these surviving data are shown as mean 6 SEM from two biological replicates performed in triplicate. *p < 0.05; *p < 0.01.
Toward this goal, we inserted an egfp gene downstream of the sigB gene in Msm chromosome to generate a strain expressing translational fusion of r B -eGFP and used the integrative plasmid pMV306 (Stover et al., 1991) to introduce a single-copy of promoter-mcherry transcriptional fusion in the Msm r B -eGFP strain. The relationship between sigB expression and activities of the ppk1 promoter from Msm or Mtb and a control promoter (Msmeg_1802p) were analyzed respectively, by this system. As shown in Fig. 7A , cells with high expression of r B exhibited high activity of ppk1 promoters from both Msm and Mtb. However, activities of the control promoter (Msmeg_1802p) in cells were not coordinated with the levels of r B in individual cells (Fig. 7A) . The correlation co-efficients between r B levels and ppk1 promoter activities in Msm and Mtb are higher than that between r B and Msmeg_1802p (Fig. 7B) . Importantly, cells with high expression levels of r B showed stronger tolerance to INH compared with cells with normal levels of r B (Fig. 7C) . Expression levels of RbpA were not shown because the fusion of RbpA-eGFP influenced the function of RbpA and increased the number of INHtolerant cells compared with the wild-type strain (data not shown), whereas r B -eGFP behaved in a manner similar to wild-type r B in controlling the formation of INH-tolerant cells (Supporting Information Fig. S7 ). Based on all these data, we concluded that RbpA and r B associate to activate transcription of ppk1, which may lead to the accumulation of intracellular polyP and increase tolerance to INH.
Discussion
To facilitate survival in the presence of drug stresses, Mtb generates a small percentage of drug-tolerant cells stochastically due to the heterogeneity in gene expression, or Mtb can enter a drug-tolerant state in response to environmental stress (Betts et al., 2002; Keren et al., 2011; Cohen et al., 2013; Wakamoto et al., 2013; Manina et al., 2015) . Several factors, including polyP and transcriptional regulators, are presumably involved in these processes (Karakousis et al., 2008; Keren et al., 2011; Singh et al., 2013) . However, mechanisms underlying the formation of drug-tolerant bacilli remain largely unknown. In this study, we characterized a transcriptional regulatory pathway of RbpA-r B -PPK1, which is shown to function in mycobacterial INH-tolerance both during the logarithmic growth phase and under nutrition starved conditions. Defined as non-genetic variation observed in individual cells, phenotypic heterogeneity plays an important role in influencing stress responses and drug susceptibility in Mtb (Dhar et al., 2016) as well as in other pathogens (Sanchez-Romero and Casadesus, 2014; Bumann, 2015) . Stochastic variation in gene expression is a key determinant of phenotypic variation (Kaern et al., 2005) . One example is the association of proposed from data shown in this study and dashed arrows indicate suggested regulatory pathway from a previous study (Hu et al., 2016). stochastic variation in katG expression to INH-tolerance in single mycobacterial cells (Wakamoto et al., 2013) . Previous studies have shown that mycobacterial r B is important for stress responses, including cell envelope stress and hypoxia (Fontan et al., 2009 ) and for tolerance to several drugs (Pisu et al., 2017; Yang et al., 2017) . These studies have been performed at the population level. The roles of variation in expression of r B in individual cells are unclear. Deletion of sigB gene did not change the MIC of mycobacteria to INH (Yang et al., 2017) , but we showed that it decreased the fraction of survivors to INH treatment both under optimal growth conditions and in the starvation model (Fig. 4) (Pisu et al., 2017) , which suggests that r B may promote Msm tolerance to INH. By using a fluorescent reporter, we demonstrated that the increased expression of r B positively correlates with INH tolerance, as measured by CFU recovery during INH treatment. We have also shown that deletion of the sigB gene decreased the fraction of INH-tolerant cells in a starvation model (Betts et al., 2002) . Importantly, expression levels of ppk1, a r B target responsible for polyP biosynthesis, varied proportionately with r B in mycobacterial populations. Based on these observations, we propose that the regulatory pathway of r B -RbpA-PPK1 may play a role in controlling the phenotypic heterogeneity in INH-susceptibility in mycobacteria (Fig. 7D) .
The activity of mycobacterial r B has been reported to be dependent on RbpA in in vitro assays (Hu et al., 2014) . RbpA protein in mycobacteria has been shown to activate the principal r A and stress response r B in in vitro transcription analyses (Hu et al., 2012; Hu et al., 2014) . Since sigA and rbpA genes are both essential (Gomez et al., 1998; Bortoluzzi et al., 2013; Hu et al., 2016) , association between RbpA and r A in vivo can be easily proposed. Although the amino acid sequence of r B is homologous to that of r A (Zhu et al., 2017) and they recognize similar promoters in in vitro transcription assays (Hu et al., 2014; Zhu et al., 2017) , evidence for the roles of protein-protein association between RbpA and r B in bacteria was lacking. In this study, we showed that mutations in r B or RbpA, which abolished their interactions, disrupted the transcriptional regulation of ppk1 and decreased the number of INH-tolerant cells under optimal growth and nutrient-starvation conditions. These data provide the first direct evidence for the role of coordinated interaction between RbpA and r B . In mycobacteria, regulation of ppk1 transcription is complex. A previous study has shown that transcription of ppk1 is induced upon phosphate starvation and this process is mediated by r E and two-component systems MprAB and SenX3-RegX3 (Sureka et al., 2007; Sanyal et al., 2013) . Here, we found that RbpA associates with r B to regulate ppk1. r E and the two-component system MprAB have also been reported to control the sigB promoter (He et al., 2006) , thus forming a complex regulatory network. The relationship between r E and r B in regulating ppk1 transcription needs further investigation. In our previous work, we found that r B could activate the rbpA promoter in mycobacteria (Hu et al., 2016; Zhu et al., 2017) . Activated RbpA can interact with r B to facilitate the transcription of a r B target (such as ppk1), which forms another regulatory loop (Fig. 7D) . In addition to the RbpA-r B -PPK1 regulatory pathway, other mechanisms might be involved in generating drugtolerant cells in mycobacteria. Intracellular polyP levels are known to be important for maintaining susceptibility to INH (Thayil et al., 2011; Chuang et al., 2013; Wakamoto et al., 2013; Chuang et al., 2015) and some other antituberculosis drugs (Singh et al., 2013) . However, a recent study has shown that accumulation of polyP in mycobacteria increased susceptibility to b-lactams and clofazimine (Chuang et al., 2016) . We do not know why polyP has different actions in controlling susceptibility to different drugs. These data suggest that unknown factors synergize to form drug-tolerant mycobacteria, which is worthy of further study. We observed an approximately twofold change in ppk1 expression, but the survival percentage increased over 100-fold for Msm WT strain after PBST treatment. These data suggest that some other mechanisms may also be involved in PBST-induced INH tolerance. Besides polyP, several other proteins and molecules have been shown to be involved in stress responses and generating drug-tolerant cells (Dahl et al., 2003; Chionh et al., 2016; Namugenyi et al., 2017) . The expression level of katG is known to be negatively correlated with INH-tolerance in mycobacterial cells (Wakamoto et al., 2013) ; and our study showed that the expression of katG was repressed during PBST treatment (Supporting Information Fig. S4A ). These data indicate that regulation of katG expression may play an important role in PBST induced INH-tolerance. The mechanism for the repression of katG expression under PBST treatment is an intriguing subject for future study. Toxin-antitoxin (TA) systems have also been thought to be essential for generating a non-growing state in several bacteria (Gerdes and Maisonneuve, 2012; Germain et al., 2015) . There are about 30 TA pairs in the Mtb genome (Ramage et al., 2009) . Whether these TA pairs are important in controlling drug-tolerance and are regulated by RbpA-r B association warrants further study. Our data herein have demonstrated that the transcriptional regulation network of RbpA-r B -PPK1 is functional in the development of INH-tolerant cells both in the logarithmic growth phase and under nutrient starvation conditions, which provides new insights to advance our understanding of the mechanisms involved in the development of drug-tolerant cells.
Experimental procedures
Bacterial strains and growth conditions
The strains, plasmids and oligonucleotides used in this study are listed in Supporting Information Tables S1 and S2. M. smegmatis mc 2 155 and strains derived from it were grown in 7H9 (Difco) broth containing 15 mM NaCl, 0.2% glycerol, 0.2% glucose and 0.05% Tween 80, or on 7H10 (Difco) plates with 0.5% glucose. When necessary, antibiotics were used at the following concentrations: hygromycin B (50 lg ml 21 for 7H9 or 7H10 and 150 lg ml 21 for LB), kanamycin (20 lg ml 21 ), streptomycin (10 lg ml 21 for 7H9 and 20 lg ml 21 for 7H10). For Msm strains carrying the pFRA42B or the pUV15TetORm plasmid, the stationary phase (cultured for 24 h) cells were transferred into fresh 7H9 medium containing 50 ng ml 21 ATc at the ratio of 1% (v/v) and incubated for 12-14 h to obtain the earlylogarithmic growth phase cells, which were used for further treatment with INH or PBST (ATc at 50 ng ml 21 was also included during these treatments).
Mutant construction and complementation
Msm Dppk1 and r B -eGFP strains were constructed as previously described (Hu et al., 2016) . Briefly, a fragment upstream and a fragment downstream of the ppk1 gene were amplified, and inserted into the plasmid pNILRB4 (Balhana et al., 2010) . For constructing r B -eGFP fusion, a fragment at the 3 0 -terminal of sigB gene and a fragment downstream of the sigB gene were amplified and overlapped with the egfp gene (to replace the stop codon). This fragment was then also inserted into the plasmid pNILRB4. These constructs were electroporated into Msm respectively. Transformants were selected by plating on 7H10 agar plates containing kanamycin, and double-crossed strains were selected by spreading onto 7H10 plates plus 10% sucrose.
The sigA knockdown strain was constructed as we previously described for rbpA knockdown strain (Hu et al., 2016) . Briefly, a fragment covering the 5 0 -flanking region upstream of the sigA promoter was overlapped with rrnB terminator to obtain an upstream fragment. The downstream fragment was composed of the ptr promoter and the 5 0 -terminal of sigA gene. These two fragments were overlapped and inserted into the pNILRB4 plasmid. The mutant strain, in which the native promoter of sigA gene was replaced by the ptr promoter, was constructed as described above. The pFRA42B (Boldrin et al., 2010) was subsequently transformed into this mutant to control sigA gene transcription.
To overexpress proteins in the mutant strains, sigB and ppk1 genes were amplified from the Msm genome respectively, and cloned into pMV261 (Stover et al., 1991) or ATc induced expression vector pUV15TetORm (Ehrt et al., 2005) . Promoters in fusion with mcherry were constructed using an integrative plasmid pMV306 (Stover et al., 1991) .
Detecting INH-tolerant cells
Msm were collected at the early-logarithmic growth phase (OD 600 0.5) and then diluted into fresh medium to CFU at approximately 10 7 . INH was added at a final concentration of 60 lg ml 21 or at concentration specifically indicated with continuous shaking at 200 rpm. Samples treated for the indicated times were serially diluted 10-fold and spread on 7H10 plates in triplicate to obtain colony-forming units (CFU). For nutrient starvation, Msm at the early-logarithmic growth phase were washed twice with PBST (PBS supplemented with 0.05% Tween 80) and incubated in PBST for 72 h with continuous shaking at 200 rpm. INH treatment was then performed as described above.
RNA extraction and qRT-PCR analyses
RNA extraction and qRT-PCR analyses were carried out as previously described (Hu et al., 2016) . Briefly, Msm cells (in early-logarithmic growth phase) before or after PBST treatment were collected, snap frozen and ground in liquid nitrogen. RNA was extracted with TRIzol (Invitrogen) and reverse transcribed to cDNA using M-MLV (Promega). An Universal SYBR Green Supermix Reagent (Bio-Rad) was used in real-time PCR reactions. Relative transcriptional levels of tested genes were normalized to the 16S rRNA levels. Each experiment was performed in duplicates and at least twice independently. Data between two groups were analyzed using the Student's t-test.
Determination of mycobacterial polyP content
Concentration of intracellular polyP was measured by a 4 0 ,6-diamidino-2-phenylindole (DAPI)-based method (AultRiche et al., 1998; Aschar-Sobbi et al., 2008) . Briefly, approximately 5 mL of bacteria at logarithmic growth phase (O.D 600 0.4) were washed and resuspended in PBST for the indicated times. Collections were suspended in 958C pre-warmed GITC buffer (5 M guanidinium thiocyanate, 50 mM Tris-HCl pH 7.0). Cells were disrupted by sonication, and total protein levels were determined by a NanoDrop (Thermo). PolyP was collected by glass milk, treated with DNase and RNase, and eluted with distilled water (958C, pH 8.0). PolyP levels were determined by adding DAPI (10 lg ml
21
). The fluorescence of excitation at 415 nm and emission at 525 nm was measured using Bio-TEK Synergy H1. A standard curve of polyP (type 65, Sigma-Aldrich), ranging from 500 to 4 lg ml 21 , was constructed.
Promoter activity assay
The Mtb_ppk1p and Msm_ppk1p fragments were amplified from Mtb and Msm respectively, and inserted into the pMV306-eGFP plasmid as previously described (Zhu et al., 2017) . Mutations in promoter region were introduced using a Site-Directed Mutagenesis Kit (Stratagene). Mycobacterial cells grown at OD 600 of approximately 0.8 were collected and resuspended in PBST. The promoter activities are indicated by relative fluorescence units (RFU, fluorescence intensities per OD 600 ) as tested by Bio-TEK Synergy H1. All assays were carried out in duplicate and each experiment was performed twice independently.
Bacterial adenylate cyclase-based two-hybrid assay
The interaction between RbpA and r B was tested through the bacterial adenylate cyclase-based two-hybrid system as previously described (Karimova et al., 1998) . In brief, the wild-type or mutated rbpA gene was cloned into the pKT25 plasmid to generate T18 fusions, and the wild-type or mutated sigB gene was cloned into the pUT18 plasmid to obtain T25 fusions. Pairs of pKT25 and pUT18 plasmids were co-transformed into E. coli BTH101. The bgalactosidase activities were tested as described previously (Hu et al., 2009) .
Protein purification and in vitro transcription
RNAP core enzyme with His-tag at the C-terminal of the b 0 subunit, r B and RbpA proteins from Mtb were expressed in the E. coli BL21(DE3) strain and purified as previously described (Hu et al., 2014; Zhu et al., 2017) . In vitro transcription reactions were performed as described with minor modifications (Zhu et al., 2017) . In brief, 200 nM RNAP core, 600 nM r factor and 800 nM RbpA were firstly mixed to assemble the RNAP holoenzyme, which was then incubated with 30 nM promoter fragment. Transcription was initiated by addition of 50 lM of each GTP, UTP and ATP, 5 lM of CTP together with 1 lCi [a-32 P]CTP. RNA samples were resolved on 16% denaturing PAGE (7 M urea).
Fluorescence imaging and FACS analysis
Live cell fluorescence microscopy of Msm was performed with the agar pad method (Young et al., 2011) . To prepare single-cell suspension, Msm cultures at logarithmic growth phase were resuspended using a 27-gauge needle and a syringe. The agar pad was prepared using 7H10 media. About 10 ml dispersed cells were placed on the top of agar pad and evaporated for 15 min. Then the pad with cells was inversely placed into a glass dish and kept at 378C for 3 h. Fluorescence images were obtained using Nikon A1 MP STORM microscope. The fluorescence intensities of mycobacteria were measured by ImageJ and more than 200 cells from each strain were quantified. The correlation between the intensities of eGFP and mCherry was analyzed using Graphpad Prism 6.
For FACS analysis, dispersed cells were passed through a 5 lm filter (Millipore) to remove clumps. The de-clumped cell suspensions were kept at 378C for 3 h and then separated by the flow cytometer. Samples at indicated fluorescence intensities were collected to a total number of 3 3 10 5 mycobacteria (sample with the highest fluorescence intensity had 1 3 10 5 mycobacteria), and suspended in 1 mL 7H9 media with INH treatment. CFU were determined at the indicated time points.
Statistical analysis
Statistical analyses were conducted using SPSS Statistics 22, and values are shown as mean 6 standard error of the mean (SEM). The p values shown were calculated using Student's t-test or ANOVA analysis. *p < 0.05; **p < 0.01.
